Diego Ulissi
Diego Ulissi (born 15 July 1989) is a professional road bicycle racer from Italy, who currently rides for UCI WorldTeam UAE Team Emirates. Ulissi is known for his abilities as a puncher, a rider who excels on steep, short climbs, and has a strong finish in small group sprints. Over his career, he has achieved notable success in both stage races and one-day races, making him one of the most versatile riders of his generation.
Early Life and Amateur Career[edit | edit source]
Diego Ulissi was born in Cecina, Tuscany, Italy. He began cycling at a young age and quickly showed promise as a junior rider. Ulissi's amateur career was highlighted by several important victories, including the prestigious U23 World Road Race Championships in 2008. His success as an amateur caught the attention of professional teams, and he turned professional in 2010 with the Lampre-Merida team, which later became UAE Team Emirates.
Professional Career[edit | edit source]
Ulissi's professional career has been marked by a series of impressive victories and consistent performances. He has won stages in Grand Tours, including the Giro d'Italia, where he has been particularly successful. Ulissi's ability to perform well on varied terrain has allowed him to win both hilly stages and stages that end in a sprint from a reduced peloton.
Notable Victories[edit | edit source]
Some of Ulissi's most notable victories include multiple stage wins at the Giro d'Italia and victories in one-day races such as the GP Montreal. His versatility has also seen him perform well in week-long stage races, with overall and stage victories in events like the Tour of Slovenia and the Giro di Sardegna.
Riding Style[edit | edit source]
Ulissi is known for his explosive power on short climbs and his ability to sprint from a small group. This combination makes him a formidable opponent in races that feature short, steep ascents followed by a flat or rolling finish. He is also a tactically astute rider, often timing his attacks to perfection.
Controversies[edit | edit source]
Ulissi's career has not been without controversy. In 2014, he faced a suspension for a doping violation related to the use of salbutamol, a substance commonly used in asthma medication. Ulissi and his team argued that the abnormal result was due to a therapeutic use exemption, and he was eventually cleared to return to racing after serving a nine-month suspension.
Personal Life[edit | edit source]
Outside of cycling, Ulissi leads a private life. He is known to reside in Tuscany, close to where he was born and raised. Ulissi is also recognized for his dedication to his family and his passion for the sport of cycling.
Legacy[edit | edit source]
Diego Ulissi's career is a testament to his resilience and versatility as a rider. Despite facing challenges, including a doping suspension, he has returned to the sport with determination and success. His achievements in both stage races and one-day races highlight his adaptability and tactical intelligence, making him a respected figure in the professional cycling community.
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD